115
The Dengue Vaccine: Promising Protection and Safety
The dengue vaccine has proven to be both effective and safe, offering significant protection against this debilitating disease. Research suggests that the vaccine is more than 50% effective in reducing the risk of contracting dengue, with long-lasting effects.
Strong Evidence of Efficacy:
- A meta-analysis of 19 scientific studies encompassing over 20,000 participants confirmed the vaccine’s efficacy in preventing dengue.
- The results showed a reduction in the risk of contracting the disease by more than 50%.
- More than 90% of those who received both doses developed antibodies against dengue, with positive responses even among those who received only one dose.
High Safety Profile:
- The dengue vaccine has a very good safety profile, with minimal side effects reported.
- This is confirmed by the first international meta-analysis on the effectiveness of TAK-003, the only vaccine approved in many European countries to combat dengue.
Promising for Travelers and Endemic Areas:
- The vaccine is effective not only for residents in endemic areas but also for travelers from non-dangerous regions.
- This offers crucial protection for travelers to popular tourist destinations where dengue is prevalent.
Conclusion:
The dengue vaccine is a promising solution for preventing this debilitating disease. With proven efficacy and a safe profile, it offers a crucial preventive strategy for both residents of endemic areas and travelers.